Literature DB >> 28384860

Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience.

Ravinder Kaur1, Bhanu Mehra2, Megh Singh Dhakad3, Ritu Goyal4, Preena Bhalla5, Richa Dewan6.   

Abstract

INTRODUCTION: Opportunistic pneumonias are a major cause of mortality and morbidity in Human Immunodeficiency Virus (HIV) reactive patients. Despite the significant role that fungi play in causation of this opportunistic mycoses, very few Indian studies have attempted to investigate the burden and aetiological spectrum of HIV/AIDS-associated fungal pneumonias. AIM: To document the prevalence of fungal aetiology in HIV/AIDS-related opportunistic pneumonias in an Indian setting; and to elucidate the various fungal opportunists responsible for the same.
MATERIALS AND METHODS: The present study was a prospective, cross-sectional analysis conducted at Maulana Azad Medical College and associated Lok Nayak Hospital, New Delhi from October 2008 to September 2011. Expectorated sputa were collected from 71 HIV reactive patients with a clinical diagnosis of pneumonia and subjected to direct microscopic examination employing Gram stain, 10% KOH wet mount and India ink preparation. In addition, direct immunofluorescence of sputum samples was performed for detection of cysts and trophozoites of Pneumocystis carinii. Also, each sputum sample was inoculated in duplicate onto Sabouraud Dextrose Agar (SDA) for culture. A blood sample was drawn from each patient and a battery of serological tests was performed, including Cryptococcal Antigen Latex Agglutination System (CALASTM) for detection of cryptococcal capsular polysaccharide antigen; Platelia™ Aspergillus EIA for detection of Aspergillus galactomannan antigen; SERION ELISA antigenCandida for detection of Candida antigen and Histoplasma DxSelect™ for detecting antibodies to Histoplasma species. Descriptive statistics were employed to depict results as proportions and figures. Further, arithmetic mean and standard deviation were calculated for central tendencies and median for non-normal/skewed distributions.
RESULTS: A definite fungal aetiology was established in 25 (35.2%) of 71 HIV reactive patients with pneumonic involvement. Of these, sputa of 21 patients yielded single fungal isolates, while mixed fungal isolates were reported in four patients. Pneumocystis carinii was the predominant fungal pathogen isolated in our study and was reported in 14 (19.7%) patients. Pulmonary aspergillosis was reported in 7 (9.9%) patients, with Aspergillus flavus (4), Aspergillus fumigatus (2) and Aspergillus niger (1) being the commonly recovered Aspergillus species. Candida pneumonia was documented in 6 (8.5%) patients and the Candida species isolated included Candida albicans in four, Candida glabrata in one and Candida tropicalis in one of these six patients respectively. Pulmonary cryptococcosis was diagnosed in 2 (2.8%) patients; a coexisting cryptococcal meningitis was documented in one of them. Furthermore, antibodies against Histoplasma species were detected in 21 (29.6%) cases suggesting its possible aetiological role.
CONCLUSION: Fungal opportunistic pneumonias are common in HIV reactive patients in Indian setting and warrant a prompt and accurate diagnostic evaluation in the form of a combination of microbiological, serological and histopathological techniques, for an effective prophylactic and therapeutic management.

Entities:  

Keywords:  Aspergillus; Candida; Cryptococcus; Pneumocystis carinii

Year:  2017        PMID: 28384860      PMCID: PMC5376915          DOI: 10.7860/JCDR/2017/24219.9277

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  23 in total

Review 1.  Pneumocystis pneumonia.

Authors:  Charles F Thomas; Andrew H Limper
Journal:  N Engl J Med       Date:  2004-06-10       Impact factor: 91.245

2.  Detection of Pneumocystis carinii in induced sputum samples of HIV positive patients.

Authors:  M Mishra; Y S Thakar; S L Akulwar; N S Tankhiwale; R M Powar
Journal:  Indian J Med Microbiol       Date:  2006-04       Impact factor: 0.985

3.  Role of PCR for diagnosing Pneumocystis jirovecii pneumonia in HIV-infected individuals in a tertiary care hospital in India.

Authors:  Kiran Chawla; Suganthi Martena; Bimala Gurung; Chiranjay Mukhopadhyay; George K Varghese; Indira Bairy
Journal:  Indian J Pathol Microbiol       Date:  2011 Apr-Jun       Impact factor: 0.740

Review 4.  Fungal infections in the immunocompromised host.

Authors:  B Wanke; M dos S Lazéra; M Nucci
Journal:  Mem Inst Oswaldo Cruz       Date:  2000       Impact factor: 2.743

5.  Two unusual cases of histoplasmosis in human immunodeficiency virus-infected individuals.

Authors:  P V Bhagwat; K Hanumanthayya; R S Tophakhane; R M Rathod
Journal:  Indian J Dermatol Venereol Leprol       Date:  2009 Mar-Apr       Impact factor: 2.545

6.  Revised surveillance case definitions for HIV infection among adults, adolescents, and children aged <18 months and for HIV infection and AIDS among children aged 18 months to <13 years--United States, 2008.

Authors:  Eileen Schneider; Suzanne Whitmore; Kathleen M Glynn; Kenneth Dominguez; Andrew Mitsch; Matthew T McKenna
Journal:  MMWR Recomm Rep       Date:  2008-12-05

7.  [Differential diagnosis of pulmonary mycobacterial infection; radiological findings mimicking tuberculous or nontuberculous mycobacterial pneumonia].

Authors:  Hiroshi Tanaka; Yuichi Yamada; Eiji Ito
Journal:  Kekkaku       Date:  2009-08

Review 8.  HIV-associated opportunistic pneumonias.

Authors:  Laurence Huang; Kristina Crothers
Journal:  Respirology       Date:  2009-05       Impact factor: 6.424

9.  Diagnosis of Pneumocystis jirovecii pneumonia in immunocompromised patients by real-time PCR: a 4-year prospective study.

Authors:  Florence Robert-Gangneux; Sorya Belaz; Matthieu Revest; Pierre Tattevin; Stéphane Jouneau; Olivier Decaux; Sylviane Chevrier; Yves Le Tulzo; Jean-Pierre Gangneux
Journal:  J Clin Microbiol       Date:  2014-07-09       Impact factor: 5.948

10.  AIDS-related opportunistic mycoses seen in a tertiary care hospital in North India.

Authors:  Anupriya Wadhwa; Ravinder Kaur; Satish Kumar Agarwal; Shyama Jain; Preena Bhalla
Journal:  J Med Microbiol       Date:  2007-08       Impact factor: 2.472

View more
  2 in total

Review 1.  Targeting the Immune System with Plant Lectins to Combat Microbial Infections.

Authors:  Jannyson J B Jandú; Roberval N Moraes Neto; Adrielle Zagmignan; Eduardo M de Sousa; Maria C A Brelaz-de-Castro; Maria T Dos Santos Correia; Luís C N da Silva
Journal:  Front Pharmacol       Date:  2017-10-04       Impact factor: 5.810

2.  Pneumocystis jirovecii Pneumonia and Human Immunodeficiency Virus Co-Infection in Western Iran.

Authors:  Arezoo Bozorgomid; Yazdan Hamzavi; Sahar Heidari Khayat; Behzad Mahdavian; Homayoon Bashiri
Journal:  Iran J Public Health       Date:  2019-11       Impact factor: 1.429

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.